1
|
Hamasaki A, Uchida T, Sadahiro M. Solo Smart stentless bioprosthesis for redo aortic valve replacement. J Card Surg 2019; 35:485-487. [PMID: 31778575 DOI: 10.1111/jocs.14374] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND In the redo aortic valve replacement (AVR), removal of the previously implanted damaged prosthesis may result in a native aortic annulus defect, making it difficult to reimplant a stented prosthesis. The Solo Smart valve, a relatively new stentless bioprosthesis, is designed for the supra-annular implantation into the wall of the sinus of Valsalva and may be a useful alternative to redo-AVR. CASE REPORT We report a successful case of redo-AVR using the Solo Smart valve. CONCLUSION The unique feature of the Solo Smart valve is the supra-annular implantation procedure in the sinus of Valsalva without annular stitches. This bioprosthesis can be a useful alternative for redo-AVR in patients with a defect of the native aortic annulus.
Collapse
Affiliation(s)
- Azumi Hamasaki
- Second Department of Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan
| | - Tetsuro Uchida
- Second Department of Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan
| | - Mitsuaki Sadahiro
- Second Department of Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan
| |
Collapse
|
2
|
Uchida T, Hamasaki A, Kuroda Y, Yamashita A, Mizumoto M, Sadahiro M. Solo Smart Stentless Bioprosthesis for Infective Valve Endocarditis with Aortic Annular Abscess. Int Heart J 2019; 60:986-989. [PMID: 31308324 DOI: 10.1536/ihj.18-518] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
So far, there is still controversy regarding the optimal prosthetic valve for patients with active infective valve endocarditis with annular abscess. Here, we report the case of a 65-year-old woman who was diagnosed with infective endocarditis associated with extensive annular abscess. The patient underwent debridement of the abscess cavity followed by aortic valve replacement using a Solo Smart (SS) stentless bioprosthesis. Postoperative recovery was uneventful, with no signs of recurrent infection. Since the SS valve is designed for supra-annular and subcoronary implantation, it is considered to be an alternative to conventional prosthetic valves in patients with infective endocarditis with aortic annular abscess.
Collapse
Affiliation(s)
- Tetsuro Uchida
- Second Department of Surgery, Faculty of Medicine, Yamagata University
| | - Azumi Hamasaki
- Second Department of Surgery, Faculty of Medicine, Yamagata University
| | - Yoshinori Kuroda
- Second Department of Surgery, Faculty of Medicine, Yamagata University
| | - Atsushi Yamashita
- Second Department of Surgery, Faculty of Medicine, Yamagata University
| | - Masahiro Mizumoto
- Second Department of Surgery, Faculty of Medicine, Yamagata University
| | - Mitsuaki Sadahiro
- Second Department of Surgery, Faculty of Medicine, Yamagata University
| |
Collapse
|
3
|
Andrade M, Saraiva F, Amorim MJ, Marinho B, Cerqueira RJ, Lourenço AP, Pinho P, Almeida J, Leite-Moreira AF. Hemodynamic and clinical performance of Solo stentless bioprosthetic aortic valves. Rev Port Cardiol 2018; 37:811-818. [PMID: 30274938 DOI: 10.1016/j.repc.2017.11.015] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2017] [Revised: 09/25/2017] [Accepted: 11/03/2017] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To report the hemodynamic profile and short- and medium-term outcomes of Freedom Solo and Solo Smart stentless aortic valves implanted at our center. METHODS Between 2009 and 2015, all patients undergoing aortic valve replacement using Solo stentless valves at our center were enrolled. Clinical and echocardiographic follow-up was carried out six months postoperatively. Survival and major events, including structural valve deterioration and non-structural valve dysfunction, endocarditis, reoperation and stroke, were assessed through medical records or telephone interview with the referring cardiologist up to November 2015 (mean and maximum follow-up 39±22 and 78 months, respectively). RESULTS Patients' (n=345) mean age was 72±8 years, 52% were female and median euroSCORE II was 2.7 (1.5-4.7). There was no intraoperative mortality and in-hospital mortality was 2.6%. Postoperatively, mean transvalvular gradient was 11.9±4.5 mmHg and effective orifice area was 1.9±0.5 cm2. Patient-prosthesis mismatch occurred in 14% but was severe in only one patient. Cumulative survival at six years was 72%. Six patients were reoperated: three due to endocarditis, two for structural prosthesis deterioration and one because of periprosthetic fistula. Five patients suffered stroke, three had medically-treated endocarditis and one had structural valve deterioration but was not considered suitable for reoperation. None of the remainder had structural valve deterioration or non-structural valve dysfunction. CONCLUSIONS Solo stentless aortic valves are safe to implant, with promising clinical outcomes in short- and medium-term assessment. Moreover, they show an excellent hemodynamic performance: low transvalvular gradients, large effective orifice areas and low incidence of patient-prosthesis mismatch.
Collapse
Affiliation(s)
- Marta Andrade
- Department of Cardiothoracic Surgery, Centro Hospitalar de São João, Porto, Portugal; Departamento de Cirurgia e Fisiologia, Unidade de Investigação Cardiovascular (UnIC), Faculdade de Medicina, Universidade do Porto, Porto, Portugal
| | - Francisca Saraiva
- Departamento de Cirurgia e Fisiologia, Unidade de Investigação Cardiovascular (UnIC), Faculdade de Medicina, Universidade do Porto, Porto, Portugal
| | - Mário J Amorim
- Department of Cardiothoracic Surgery, Centro Hospitalar de São João, Porto, Portugal; Departamento de Cirurgia e Fisiologia, Unidade de Investigação Cardiovascular (UnIC), Faculdade de Medicina, Universidade do Porto, Porto, Portugal
| | - Benjamim Marinho
- Department of Cardiothoracic Surgery, Centro Hospitalar de São João, Porto, Portugal; Departamento de Cirurgia e Fisiologia, Unidade de Investigação Cardiovascular (UnIC), Faculdade de Medicina, Universidade do Porto, Porto, Portugal
| | - Rui J Cerqueira
- Department of Cardiothoracic Surgery, Centro Hospitalar de São João, Porto, Portugal; Departamento de Cirurgia e Fisiologia, Unidade de Investigação Cardiovascular (UnIC), Faculdade de Medicina, Universidade do Porto, Porto, Portugal
| | - André P Lourenço
- Departamento de Cirurgia e Fisiologia, Unidade de Investigação Cardiovascular (UnIC), Faculdade de Medicina, Universidade do Porto, Porto, Portugal; Department of Anesthesiology, Centro Hospitalar de São João, Porto, Portugal
| | - Paulo Pinho
- Department of Cardiothoracic Surgery, Centro Hospitalar de São João, Porto, Portugal; Departamento de Cirurgia e Fisiologia, Unidade de Investigação Cardiovascular (UnIC), Faculdade de Medicina, Universidade do Porto, Porto, Portugal
| | - Jorge Almeida
- Department of Cardiothoracic Surgery, Centro Hospitalar de São João, Porto, Portugal; Departamento de Cirurgia e Fisiologia, Unidade de Investigação Cardiovascular (UnIC), Faculdade de Medicina, Universidade do Porto, Porto, Portugal
| | - Adelino F Leite-Moreira
- Department of Cardiothoracic Surgery, Centro Hospitalar de São João, Porto, Portugal; Departamento de Cirurgia e Fisiologia, Unidade de Investigação Cardiovascular (UnIC), Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
| |
Collapse
|
4
|
Andrade M, Saraiva F, Amorim MJ, Marinho B, Cerqueira RJ, Lourenço AP, Pinho P, Almeida J, Leite-Moreira AF. Hemodynamic and clinical performance of Solo stentless bioprosthetic aortic valves. REVISTA PORTUGUESA DE CARDIOLOGIA (ENGLISH EDITION) 2018. [DOI: 10.1016/j.repce.2017.11.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
5
|
Fleerakkers J, Schepens M, Ranschaert W, Verrelst P, Graulus E. Aortic valve replacement using the Freedom SOLO stentless bioprosthesis: clinical and haemodynamic performance in 625 patients at medium-term follow-up. Eur J Cardiothorac Surg 2018; 54:1073-1080. [DOI: 10.1093/ejcts/ezy202] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/09/2018] [Accepted: 04/13/2018] [Indexed: 11/12/2022] Open
Affiliation(s)
| | - Marc Schepens
- Department of Cardiac Surgery, AZ St-Jan, Brugge, Belgium
| | | | - Paul Verrelst
- Department of Cardiac Surgery, AZ St-Jan, Brugge, Belgium
| | - Eric Graulus
- Department of Cardiac Surgery, AZ St-Jan, Brugge, Belgium
| |
Collapse
|
6
|
Joyce DL. A stentless strategy for the small annulus. J Thorac Cardiovasc Surg 2016; 153:559-560. [PMID: 27938899 DOI: 10.1016/j.jtcvs.2016.10.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/31/2016] [Accepted: 10/31/2016] [Indexed: 10/20/2022]
Affiliation(s)
- David L Joyce
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
| |
Collapse
|